Pfiz­er inks Latin Amer­i­can dis­tri­b­u­tion deal for now ful­ly ap­proved Covid-19 vac­cine

Hot off of a full FDA ap­proval, Pfiz­er has reached a dis­tri­b­u­tion agree­ment with a Brazil­ian bio­phar­ma to dis­trib­ute Covid-19 vac­cine Comir­naty in Latin Amer­i­ca, the com­pa­ny an­nounced Thurs­day.

Eu­ro­far­ma will man­u­fac­ture the Pfiz­er/BioN­Tech Covid-19 vac­cine, and dis­trib­ute it ex­clu­sive­ly through­out the re­gion, Pfiz­er said. The drug sub­stance will come from US fa­cil­i­ties, and fin­ished dose man­u­fac­tur­ing will start in 2022. The site com­pa­ny will churn out 100 mil­lion dos­es a year, if all goes ac­cord­ing to plan.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER